Top

Published in:

Open Access 01-12-2015 | Breast

Breast MRI: EUSOBI recommendations for women’s information

Authors: Ritse M. Mann, Corinne Balleyguier, Pascal A. Baltzer, Ulrich Bick, Catherine Colin, Eleanor Cornford, Andrew Evans, Eva Fallenberg, Gabor Forrai, Michael H. Fuchsjäger, Fiona J. Gilbert, Thomas H. Helbich, Sylvia H. Heywang-Köbrunner, Julia Camps-Herrero, Christiane K. Kuhl, Laura Martincich, Federica Pediconi, Pietro Panizza, Luis J. Pina, Ruud M. Pijnappel, Katja Pinker-Domenig, Per Skaane, Francesco Sardanelli, for the European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition

Published in: European Radiology | Issue 12/2015

Abstract

This paper summarizes information about breast MRI to be provided to women and referring physicians. After listing contraindications, procedure details are described, stressing the need for correct scheduling and not moving during the examination. The structured report including BI-RADS® categories and further actions after a breast MRI examination are discussed. Breast MRI is a very sensitive modality, significantly improving screening in high-risk women. It also has a role in clinical diagnosis, problem solving, and staging, impacting on patient management. However, it is not a perfect test, and occasionally breast cancers can be missed. Therefore, clinical and other imaging findings (from mammography/ultrasound) should also be considered. Conversely, MRI may detect lesions not visible on other imaging modalities turning out to be benign (false positives). These risks should be discussed with women before a breast MRI is requested/performed. Because breast MRI drawbacks depend upon the indication for the examination, basic information for the most important breast MRI indications is presented. Seventeen notes and five frequently asked questions formulated for use as direct communication to women are provided. The text was reviewed by Europa Donna–The European Breast Cancer Coalition to ensure that it can be easily understood by women undergoing MRI.

Key Points

• Information on breast MRI concerns advantages/disadvantages and preparation to the examination

• Claustrophobia, implantable devices, allergic predisposition, and renal function should be checked

• Before menopause, scheduling on day 7–14 of the cycle is preferred

• During the examination, it is highly important that the patient keeps still

• Availability of prior examinations improves accuracy of breast MRI interpretation

Available only for authorised users

Heywang SH, Hahn D, Schmidt H et al (1986) MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 10:199–204CrossRefPubMed

Kaiser WA, Zeitler E (1989) MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170:681–686CrossRefPubMed

Kuhl C (2007) The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 244:356–378CrossRefPubMed

Turnbull LW (2009) Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer. NMR Biomed 22:28–39CrossRefPubMed

Kuhl CK (2007) Current status of breast MR imaging. Part 2. Clinical applications. Radiology 244:672–691CrossRefPubMed

Mann RM, Kuhl CK, Kinkel K, Boetes C (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 18:1307–1318PubMedCentralCrossRefPubMed

Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46:1296–1316CrossRefPubMed

Scheurlen K, Schnitzer A, Krammer J, et al (2014) Value of galactography for the diagnostic work-up of pathological nipple discharge in multimodal breast diagnostics : Part 2: a systematic review of the literature. Radiologe 54:160–166

Londero V, Zuiani C, Linda A et al (2012) High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision. AJR Am J Roentgenol 199:W240–W250CrossRefPubMed

10.

Sardanelli F, Helbich T, for the European Society of Breast Imaging (EUSOBI) (2012) Mammography: EUSOBI recommendations for women’s information. Insights Imaging 3:7–10PubMedCentralCrossRefPubMed

11.

Eshed I, Althoff CE, Hamm B, Hermann KG (2007) Claustrophobia and premature termination of magnetic resonance imaging examinations. J Magn Reson Imaging 26:401–404CrossRefPubMed

12.

Institute for magnetic resonance safety, education, and research. At: http://www.mrisafety.com/. Accessed on 22 Aug 2014

13.

Thomsen HS, Morcos SK, Almen T et al (2013) Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 23:307–318CrossRefPubMed

14.

Cova MA, Stacul F, Quaranta R et al (2014) Radiological contrast media in the breastfeeding woman: a position paper of the Italian Society of Radiology (SIRM), the Italian Society of Paediatrics (SIP), the Italian Society of Neonatology (SIN) and the Task Force on Breastfeeding, Ministry of Health, Italy. Eur Radiol 24:2012–2022CrossRefPubMed

15.

Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137–144CrossRefPubMed

16.

Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Garrido L (2005) Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J 11:236–241CrossRefPubMed

17.

Baltzer PA, Dietzel M, Vag T et al (2011) Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy. Röfo 183:441–447PubMed

18.

DeMartini WB, Liu F, Peacock S et al (2012) Background parenchymal enhancement on breast MRI: impact on diagnostic performance. AJR Am J Roentgenol 198:W373–W380CrossRefPubMed

19.

Kajihara M, Goto M, Hirayama Y et al (2013) Effect of the menstrual cycle on background parenchymal enhancement in breast MR imaging. Magn Reson Med Sci 12:39–45CrossRefPubMed

20.

Ellis RL (2009) Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle. AJR Am J Roentgenol 193:1738–1740CrossRefPubMed

21.

Hegenscheid K, Schmidt CO, Seipel R et al (2012) Contrast enhancement kinetics of normal breast parenchyma in dynamic MR mammography: effects of menopausal status, oral contraceptives, and postmenopausal hormone therapy. Eur Radiol 22:2633–2640CrossRefPubMed

22.

American College of Radiology (ACR) Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas). Reston, Va, U.S.A.: American College of Radiology; 2013. At: http://www.acr.org/Quality-Safety/Resources/BIRADS/MRI. Accessed on 21 Aug 2014

23.

Pinker-Domenig K, Bogner W, Gruber S et al (2012) High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer? Eur Radiol 22:322–330CrossRefPubMed

24.

Spick C, Baltzer PA (2014) Diagnostic utility of second-Look US for breast lesions identified at MR imaging: systematic review and meta-analysis. Radiology 273:401–409CrossRefPubMed

25.

Heywang-Köbrunner SH, Sinnatamby R, Consensus Group et al (2009) Interdisciplinary consensus on the uses and technique of MR-guided vacuum-assisted breast biopsy (VAB): results of a European consensus meeting. Eur J Radiol 72:289–294CrossRefPubMed

26.

Smith H, Chetlen AL, Schetter S et al (2014) PPV(3) of suspicious breast MRI findings. Acad Radiol 21:1553–1562CrossRefPubMed

27.

Comstock C, Sung JS (2013) BI-RADS 3 for magnetic resonance imaging. Magn Reson Imaging Clin N 21:561–570CrossRef

28.

Spick C, Szolar DH, Baltzer PA et al (2014) Rate of malignancy in MRI-detected probably benign (BI-RADS 3) lesions. AJR Am J Roentgenol 202:684–689CrossRefPubMed

29.

Liberman L, Morris EA, Benton CL, Abramson AF, Dershaw DD (2003) Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women. Cancer 98:377–388CrossRefPubMed

30.

Neubauer H, Li M, Kuehne-Heid R, Schneider A, Kaiser WA (2003) High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 76:3–12CrossRefPubMed

31.

Kuhl CK, Schrading S, Bieling HB et al (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370:485–492CrossRefPubMed

32.

Facius M, Renz DM, Neubauer H et al (2007) Characteristics of ductal carcinoma in situ in magnetic resonance imaging. Clin Imaging 31:394–400CrossRefPubMed

33.

Dorrius MD, Pijnappel RM, der Jansen-van Weide MC, Oudkerk M (2010) Breast magnetic resonance imaging as a problem-solving modality in mammographic BI-RADS 3 lesions. Cancer Imaging 10:S54–S58PubMedCentralCrossRefPubMed

34.

Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75–89CrossRefPubMed

35.

Lord SJ, Lei W, Craft P et al (2007) A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43:1905–1917CrossRefPubMed

36.

Warner E, Messersmith H, Causer P et al (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148:671–679CrossRefPubMed

37.

Riedl CC, Ponhold L, Flory D et al (2007) Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res 13:6144–6152CrossRefPubMed

38.

Kuhl C, Weigel S, Schrading S et al (2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 28:1450–1457CrossRefPubMed

39.

Sardanelli F, Podo F, Santoro F et al (2011) Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results. Invest Radiol 46:94–105CrossRefPubMed

40.

Taneja C, Edelsberg J, Weycker D et al (2009) Cost-effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol 6:171–179CrossRefPubMed

41.

Sung JS, Lee CH, Morris EA, Oeffinger KC, Dershaw DD (2011) Screening breast MR imaging in women with a history of chest irradiation. Radiology 259:65–71CrossRefPubMed

42.

Ng AK, Garber JE, Diller LR et al (2013) Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol 31:2282–2288CrossRefPubMed

43.

Tieu MT, Cigsar C, Ahmed S (2014) Breast cancer detection among young survivor of pediatric Hodgkin lymphoma with screening magnetic resonance imaging. Cancer 120:2507–2513CrossRefPubMed

44.

Phi XA, Houssami N, Obdeijn IM et al (2015) Magnetic resonance imaging improves breast screening Sensitivity in BRCA Mutation Carriers Age ≥ 50 Years: Evidence From an Individual Patient Data Meta-Analysis. J Clin Oncol 33:349–356CrossRefPubMed

45.

Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571CrossRefPubMed

46.

Peters NH, van Esser S, van den Bosch MA et al (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer 47:879–886CrossRefPubMed

47.

Sakakibara M, Nagashima T, Sangai T et al (2008) Breast-conserving surgery using projection and reproduction techniques of surgical-position breast MRI in patients with ductal carcinoma in situ of the breast. J Am Coll Surg 207:62–68CrossRefPubMed

48.

Gonzalez V, Sandelin K, Karlsson A et al (2014) Preoperative MRI of the breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study. World J Surg 38:1685–1693CrossRefPubMed

49.

Mann RM, Loo CE, Wobbes T et al (2010) The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 119:415–422CrossRefPubMed

50.

Houssami N, Turner R, Morrow M (2013) Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg 257:249–255CrossRefPubMed

51.

Di Leo G, Trimboli RM, Benedek A et al (2015) Magnetic resonance imaging for selecting patients for partial breast irradiation: a systematic review and meta-analysis. Radiology. doi:10.1148/radiol.2015142508

52.

Holland R, Veling SH, Mravunac M, Hendriks JH (1985) Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56:979–990CrossRefPubMed

53.

Plana MN, Carreira C, Muriel A et al (2012) Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. Eur Radiol 22:26–38CrossRefPubMed

54.

Pediconi F, Catalano C, Roselli A et al (2007) Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 243:670–680CrossRefPubMed

55.

Hartman M, Czene K, Reilly M et al (2007) Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol 25:4210–4216CrossRefPubMed

56.

Robertson C, Arcot Ragupathy SK, Boachie C et al (2011) The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation. Health Technol Assess 15:v-322CrossRef

57.

Hold PM, Alam S, Pilbrow WJ et al (2012) How should we investigate breast implant rupture? Breast J 18:253–256CrossRefPubMed

58.

Brown SL, Middleton MS, Berg WA, Soo MS, Pennello G (2000) Prevalence of rupture of silicone gel breast implants revealed on MR imaging in a population of women in Birmingham, Alabama. AJR Am J Roentgenol 175:1057–1064CrossRefPubMed

59.

Marinovich ML, Sardanelli F, Ciatto S et al (2012) Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI. Breast 21:669–677CrossRefPubMed

60.

Marinovich ML, Houssami N, Macaskill P et al (2013) Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. J Natl Cancer Inst 105:321–333CrossRefPubMed

61.

Marinovich ML, Macaskill P, Irwig L et al (2013) Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy. Br J Cancer 109:1528–1536PubMedCentralCrossRefPubMed

62.

Lu H, Xu YL, Zhang SP et al (2011) Breast magnetic resonance imaging in patients with occult breast carcinoma: evaluation on feasibility and correlation with histopathological findings. Chin Med J (Engl) 124:1790–1795

Title: Breast MRI: EUSOBI recommendations for women’s information
Authors: Ritse M. Mann
Corinne Balleyguier
Pascal A. Baltzer
Ulrich Bick
Catherine Colin
Eleanor Cornford
Andrew Evans
Eva Fallenberg
Gabor Forrai
Michael H. Fuchsjäger
Fiona J. Gilbert
Thomas H. Helbich
Sylvia H. Heywang-Köbrunner
Julia Camps-Herrero
Christiane K. Kuhl
Laura Martincich
Federica Pediconi
Pietro Panizza
Luis J. Pina
Ruud M. Pijnappel
Katja Pinker-Domenig
Per Skaane
Francesco Sardanelli
for the European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition
Publication date: 01-12-2015
Publisher: Springer Berlin Heidelberg
Published in: European Radiology / Issue 12/2015
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-015-3807-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Breast MRI: EUSOBI recommendations for women’s information

Abstract

Key Points

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Key Points

Please log in to get access to this content

Other articles of this Issue 12/2015

Cardiac MRI assessment of right ventricular function: impact of right bundle branch block on the evaluation of cardiac performance parameters

Four-year cardiac magnetic resonance (CMR) follow-up of patients treated with percutaneous pulmonary valve stent implantation

Hypodense liver lesions in patients with hepatic steatosis: do we profit from dual-energy computed tomography?

Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013

C-Arm Cone-Beam CT Virtual Navigation-Guided Percutaneous Mediastinal Mass Biopsy: Diagnostic Accuracy and Complications

Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging